What is Disc Medicine's preferred stock?

Disc Medicine (IRON) reported preferred stock of $0 in Q1 2026.

What does preferred stock mean?

Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.

Disc Medicine IRON Preferred Stock

Preferred Stock at other companies

Protagonist TherapeuticsPTGX

$0—

Agios PharmaceuticalsAGIO

$0—

Travere Therapeutics, Inc.TVTX

$0—

BridgeBio PharmaBBIO

$0—

Other financials

Income statement

See full

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

See full

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

See full

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

See full

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

See full

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Disc Medicine's preferred stock?: Disc Medicine (IRON) reported preferred stock of $0 in Q1 2026.
What does preferred stock mean?: Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.